- Home
- ULCC vs ORIC Comparison
ULCC vs ORIC Comparison
Compare ULCC & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULCC
- ORIC
- Stock Information
- Founded
- ULCC 1994
- ORIC 2014
- Country
- ULCC United States
- ORIC United States
- Employees
- ULCC N/A
- ORIC N/A
- Industry
- ULCC Air Freight/Delivery Services
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- ULCC Consumer Discretionary
- ORIC Health Care
- Exchange
- ULCC Nasdaq
- ORIC Nasdaq
- Market Cap
- ULCC 1.1B
- ORIC 1.1B
- IPO Year
- ULCC 2021
- ORIC 2020
- Fundamental
- Price
- ULCC $3.68
- ORIC $13.34
- Analyst Decision
- ULCC Hold
- ORIC Strong Buy
- Analyst Count
- ULCC 9
- ORIC 8
- Target Price
- ULCC $5.63
- ORIC $16.57
- AVG Volume (30 Days)
- ULCC 3.9M
- ORIC 1.5M
- Earning Date
- ULCC 11-05-2025
- ORIC 11-06-2025
- Dividend Yield
- ULCC N/A
- ORIC N/A
- EPS Growth
- ULCC N/A
- ORIC N/A
- EPS
- ULCC N/A
- ORIC N/A
- Revenue
- ULCC $3,778,000,000.00
- ORIC N/A
- Revenue This Year
- ULCC $1.14
- ORIC N/A
- Revenue Next Year
- ULCC $13.33
- ORIC N/A
- P/E Ratio
- ULCC N/A
- ORIC N/A
- Revenue Growth
- ULCC 4.60
- ORIC N/A
- 52 Week Low
- ULCC $2.89
- ORIC $3.90
- 52 Week High
- ULCC $10.26
- ORIC $14.93
- Technical
- Relative Strength Index (RSI)
- ULCC 36.60
- ORIC 53.61
- Support Level
- ULCC $4.11
- ORIC $11.71
- Resistance Level
- ULCC $4.36
- ORIC $13.80
- Average True Range (ATR)
- ULCC 0.24
- ORIC 0.69
- MACD
- ULCC -0.04
- ORIC -0.11
- Stochastic Oscillator
- ULCC 1.35
- ORIC 50.63
About ULCC Frontier Group Holdings Inc.
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.